Sign inJoin waitlistJoin the waitlist

Tyler Gunter

Associate Professor · University of Oklahoma College of Medicine

Credentials: · · ·

History

University of Oklahoma College of Medicine
Present

Radiation Oncology
University of Oklahoma College of Medicine
2015–2019
Preliminary or Transitional Year
2014–2015
University of Oklahoma College of Medicine
2010–2014

Research

A genetic mosaic approach for neural circuit mapping in Drosophila
Proceedings of the National Academy of Sciences of the United States of America · 2010 · 64 citations
Gross tumour volume variations in primary non-small-cell lung cancer during the course of treatment with stereotactic body radiation therapy
Journal of Medical Imaging and Radiation Oncology · 2014 · First of 6 authors · 8 citations
Resection and radiotherapy for intracranial ependymoma: a multiinstitutional 50-year experience
Journal of neurosurgery · 2022 · 6 citations

Chance Matthiesen
3 papers
OA
Ozer Algan
3 papers
Christopher Graffeo
2 papers · 2 as a fellow
Ian Dunn
2 papers
Shearwood McClelland
2 papers
Abdul Qadar
1 paper
AA
Abeer Arain
1 paper
Adam Dicker
1 paper
Anthony Alleman
1 paper
Arnab Chakravarti
1 paper
Avital Perry
1 paper
BS
Baylee Stevens
1 paper · 1 as a resident

Clinical trials

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Site PI · Recruiting · Phase 3
Canadian Cancer Trials Group
2025–2030
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2032
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Site PI · Recruiting · Phase 3
NRG Oncology
2023–2041
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Site PI · Recruiting · Phase 2
NRG Oncology
2023–2033